FDA approves CLAIRITY BREAST, a new AI breast cancer prediction tool that helps doctors assess five-year risk from routine ...

The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...

A former FDA reviewer offers advice to help innovative medtech avoid new and more dangerous pitfalls as experts leave the ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

More and more devices using AI and machine learning technology are becoming available for purchase, something that’s just as ...

Elon Musk’s feud with President Donald Trump could especially weigh on Musk’s companies because of their reliance on the ...

Investing.com -- Unicycive Therapeutics Inc (NASDAQ: UNCY) stock plunged 35.3% after the clinical-stage biotechnology company announced that the U.S. Food and Drug Administration (FDA) identified ...

We recently published a list of 15 Stocks That Stole The Show Last Week. In this article, we are going to take a look at ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

Phathom Pharmaceuticals, Inc.'s FDA-granted exclusivity for Voquezna positions it as a GI market leader. Click here to find ...

Clever Culture Systems is gaining traction with its AI-enabled tool to ensure that ultra-sterile drug facilities stay that way ...